Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Investment pacts, not MoUs, to be signed at Pak-China pharma conference: minister
ISLAMABAD: Health Minister Mustafa Kamal on Tuesday said a number of investment agreements, instead of memorandums of understanding (MoUs), will be signed during the Pak-China Pharmaceutical and Healthcare B2B Investment Conference, which begins on…
Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US
FDA endorses key elements of the proposed Phase 2 dose-ranging study and openness to a single pivotal Phase 3 study to support a future NDA Amsterdam, the Netherlands, 16 July 2026 — Arletta Pharma Solutions, a clinical-stage…
Sun Pharma gets nod from South African regulator for generic semaglutide injection
Sun Pharmaceutical Industries Ltd. on Wednesday (July 15, 2026) said it has received approval from the South African regulator to manufacture and market a generic version of semaglutide injection in the country for treatment of adults with type 2…
HC Wainwright Lowers Earnings Estimates for NervGen Pharma
NervGen Pharma (NASDAQ:NGEN - Free Report) - Investment analysts at HC Wainwright cut their Q2 2026 earnings per share estimates for NervGen Pharma in a research note issued on Tuesday, July 14th. HC Wainwright analyst R. Selvaraju now anticipates…
Athira Pharma, Inc. (NASDAQ:LONA) Receives Average Rating of 'Hold' from Analysts
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) has earned an average rating of 'Hold' from the five research firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has…
BridgeBio Pharma, Inc. $BBIO Shares Purchased by Principal Financial Group Inc.
Principal Financial Group Inc. raised its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 1.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,330,415…
The Big Pharma Psychedelic Buyout Spree Has Officially Begun
Massive validation for psychedelics…not as drugs, but as investments could be moments away. Just months after I argued for the millionth time that psychedelic drug developers were likely to become acquisition targets as the sector gained…
Why Customer Care Is More Of A Growth Engine Than A Cost Center
Jennifer Waters, SVP at BioCareSD, is a leading voice in specialty pharma, championing transparency and industry innovation. The pop-up chatbot. The automated phone tree. The “your call is very important to us” recording…
Chinese drugmakers with big ambitions struggle to recruit staff for global expansion
Leading Chinese drugmakers with global ambitions such as Jiangsu Hengrui Pharmaceuticals and CanSino Biologics are struggling to recruit internationally experienced staff needed to develop and commercialise promising medicines overseas, industry…
Merck's cholesterol pill gets U.S. FDA approval
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator's nod, bolstering the drugmaker's efforts to diversify beyond its blockbuster cancer treatment Keytruda. Keytruda…
Nvidia unveils new AI model and expands Japan's physical AI ecosystem
Nvidia introduced its new AI model Cosmos 3 Edge. The company plans to expand physical AI ecosystem in Japan with local partners. It will also collaborate with local companies in healthcare sector. Samuel Boivin | Nurphoto | Getty Images Nvidia…
Genesis Energy: The Operating Inflection Precedes The Balance-Sheet Inflection (NYSE:GEL)
Genesis Energy is rated hold, balancing operational improvements with ongoing balance sheet constraints and limited near-term upside for common unitholders. GEL's offshore pipeline segment offers growth with minimal new capex, but recent Shenandoah…
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?
The iShares U.S. Pharmaceuticals ETF (IHE +0.14%) offers heavy exposure to pharmaceutical giants and a higher yield, while the State Street SPDR S&P Pharmaceuticals ETF (XPH +1.19%) provides broader, more equal-weighted exposure. Both funds target…
The Best Careers Are Built On Taking Risk, Not Hedging Your Bets
Bill Holodnak, CEO and Founder of Occam Global, an executive search and advisory firm focused on leadership across the innovation economy. There's a persistent belief that career success follows a rational path: work hard, make smart decisions and…
The roots of the US fentanyl problem: A look at three waves of the opioid crisis
The US fentanyl crisis, also known as the opioid crisis, has unfolded in three successive waves since the mid-1990s: the abuse of the prescription opioid OxyContin, the surge of fentanyl-laced heroin, and the proliferation of illicit synthetic…
Receive a Daily briefing on Pharma Industry News
Get Started